FindTrial
Sign In

Role of Regurgitation test in detecting infection and blockage of lacrimal sac area among camp patients coming for cataract surgery at our hospital.

Regurgitation on Pressure Over the Lacrimal Sac (ROPLAS) as a screening tool in excluding dacryocystitis among patients undergoing bulk outreach cataract surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046387
Enrollment
1000
Registered
2022-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H044- Chronic inflammation of lacrimal passages Health Condition 2: H045- Stenosis and insufficiency of lacrimal passages

Interventions

Intervention1: ROPLAS and Lacrimal Syringing: ROPLAS will take 30 seconds and Lacrimal syringing will take around 1 minute. ROPLAS is a screening tool to detect dacryocystitis. In this study we are co

Sponsors

SHIVAM SRIVASTAVA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.FIT PATIENTS WHO ARE PLANNED FOR CATARACT SURGERY 2.AGE GREATER THAN 50 YEARS

Exclusion criteria

Exclusion criteria: 1.SINGLE EYED 2.PATIENT DIFFICULT TO ASSESS DUE TO PHYSICAL OR MENTAL HANDICAP 3.INABILITY TO GIVE INFORMED CONSENT 4.HISTORY OF OCULAR INJURY IN RECENT PAST

Design outcomes

Primary

MeasureTime frame
SENSITIVITY AND SPECIFICITY OF ROPLAS WILL BE DETERMINEDTimepoint: ROPLAS WILL BE DONE IN EACH PATIENT AND AFTER ONE HOUR LACRIMAL SYRINGING WILL BE DONE—

Secondary

MeasureTime frame
POSITIVE PREDICTIVE VALUE, NEGATIVE PREDICTIVE VALUE AND ACCURACY OF ROPLAS WILL BE DETERMINEDTimepoint: ROPLAS AT BASELINE AND LACRIMAL SYRINGING AFTER ONE HOUR—

Countries

India

Contacts

Public ContactSHIVAM SRIVASTAVA

SANKARA EYE HOSPITAL, PANAUPURVA,TATIYAGANJ,KANPUR UP IND

sharadjnmc@gmail.com7081610454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026